WHO ICTRP trial
Comparison of topical ?% Methimazole and 4 % Hydroquinone effect on melasma
IRCT20091012002581N9 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20091012002581N9 |
|---|---|
| Public title | Comparison of topical ?% Methimazole and 4 % Hydroquinone effect on melasma |
| Scientific title | Comparison of the effect of topical Methimazole 5% versus topical Hydroquinone 4% on the improvement of melasma lesions |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | melasma. Chloasma;L81.1 |
| Interventions | Intervention 1: Intervention group: 5% topical methymazole cream that has been formulated in Tabriz University of Medical Sciencses Faculty of Pharmacy, is provided to the patients and they are asked to apply this cream to the right side of… |
| Registration date | Feb 21, 2023 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: